Double Seropositive Myasthenia Gravis Successfully Treated With Rituximab
- PMID: 36409348
- DOI: 10.1097/CND.0000000000000410
Double Seropositive Myasthenia Gravis Successfully Treated With Rituximab
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- Drachman DB. Myasthenia gravis. Semin Neurol. 2016;36:419–424.
-
- Zouvelou V. Double seropositive myasthenia gravis: a 5-year follow-up. Muscle Nerve. 2018;57:E129.
-
- Zouvelou V, Psimenou E. AChR- and MuSK-positive myasthenia gravis: double trouble. J Neuroimmunol. 2020;348:577364.
-
- Seth V, Kushwaha S, Bapat P, et al. Is double-seropositive myasthenia gravis a distinct subtype? Acta Neurol Belg. 2021 [epub ahead of print] doi: 10.1007/s13760-021-01759-2. - DOI
-
- Zhang J, Chen Y, Chen J, et al. AChR Ab and MuSK Ab double seropositive myasthenia gravis. A distinct subtype? Neurol Sci. 2021;42:863–869.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
